Clinical Trial Update: An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oxybutynin chloride plus tamsulosin versus placebo plus tamsulosin for lower urinary tract symptoms; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms

Drugs mentioned

• Tamsulosin hydrochloride (tamsulosin hydrochloride)
• oxybutynin (oxybutynin)

Snippet

Sponsor: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Conditions: Urination Disorders | Phase 3 | Status: COMPLETED